Coronary atherosclerosis and cardiovascular mortality in hemophilia

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 1, 2010, Pages 208-211

  Foley, C J ^a   Nichols, L ^a   Jeong, K ^c   Moore, C G ^c   Ragni, M V ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Hemophilia Center of Western Pennsylvania   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BLOOD CLOTTING FACTOR 8;

ADULT; AUTOPSY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; HEMOPHILIA A; HEMOPHILIA B; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISCHEMIC HEART DISEASE; LETTER; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SYMPTOM;

ADOLESCENT; ADULT; AGED; AUTOPSY; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CORONARY STENOSIS; CROSS-SECTIONAL STUDIES; HEMOPHILIA A; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 73049107202     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03669.x     Document Type: Letter

References (22)

1. Kulkarni R, Soucie JM, Evatt BL. Prevalence and risk factors for heart disease among males with hemophilia. Am J Hematol 2005, 79:36-42.
2. Ragni M, Belle SH, Jaffe R, Duerstein SL, Bass DC, McMillan CW, Lovrien EW, Aledort LM, Kisker CT, Stabler SP, Hoots WK, Hilgartner MW, Cox-Gill J, Buchanan GR, Sanders NL, Brettler DB, Barron LE, Goldsmith JC, Ewenstein B, Smith KJ. AIDS-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia. Blood 1993, 81:1889-97.
3. Triemstra M, Rosendaal F, Smit C, van der Ploeg HM, Briët E. Mortality in patients with hemophilia: changes in a Dutch population from 1986 to 1992 and 1973 to 1986. Ann Intern Med 1995, 123:823-7.
4. Plug I, van der Bom JG, Peters M, Mauser-Bunschoten EP, De Goede-Bolder A, Heijnen L, Smit C, Willemse J, Rosendaal FR. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost 2006, 4:510-6.
5. Darby SC, Kan SW, Spooner RJ, Giangrande PLF, Hill FGH, Hay CRM, Lee CA, Ludlam CA, Williams M. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 2007, 110:815-25.
6. Šrámek A, Kriek M, Rosendaal FR. Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet 2003, 362:351-4.
7. Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep vein thrombosis. Lancet 1995, 345:152-5.
8. Morange PE, Bickel C, Nicaud V, Schnabel R, Rupprecht HJ, Peetz D, Lackner KJ, Cambien F, Blankenberg S. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene Study. Arterioscler Thromb Vasc Biol 2006, 26:2793-9.
9. Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, Weltermann A, Speiser W, Lechner K, Eichinger S. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000, 343:457-62.
10. Khallou-Laschet J, Caligiuri E, Tupin E, Gaston AT, Poirier B, Groyer E, Urbain D, Maisnier-Patin S, Sarkar R, Kaveri SV, Lacroix-Desmazes S, Nicoletti A. Role of the intrinsic coagulation pathway in atherogenesis assessed in hemophilic apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2005, 25:123-6.
11. Bilora F, Boccioletti V, Zanon E, Petrobelli F, Girolami A. Hemophilia A, von Willebrand disease and atherosclerosis of abdominal aorta and leg arteries: factor VIII and von Willebrand factor defects appear to protect abdominal arteries from atherosclerosis. Clin Appl Thromb Haemost 2001, 7:311-3.
12. Bilora F, Zanon E, Petrobelli F, Cavraro M, Prandoni P, Pagnan A, Girolami A. Does hemophilia protect against atherosclerosis? A case-control study. Clin Appl Thromb Haemost 2006, 12:193-8.
13. Bilora F, Zanon E, Casonato A, Bertomoro A, Petrobelli F, Cavrano M, Campagnolo E, Girolami A. Type IIB von Willebrand disease: role of qualitative defects in atherosclerosis and endothelial dysfunction. Clin Appl Thromb Haemost 2007, 13:384-90.
14. Šrámek A, Reiber J, Gerrits W, Rosendaal F. Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency. Circulation 2001, 104:762-7.
15. Šrámek A, Bucciarelli P, Federici AB, Mannucci PM, de Rosa V, Castaman G, Morfini M, Mazzucconi MG, Rocino A, Shiavoni M, Scaraggi FA, Reiber JH, Rosendaal FR. Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patients. Circulation 2004, 109:740-4.
16. Bilora F, dei Rossi C, Girolami R, Casonato A, Zanon E, Bertomoro A, Girolami A. Do hemophilia A and von Willebrand disease protect against carotid atherosclerosis? A comparative study between coagulopathies and normal subjects by means of carotid echo-color doppler scan. Clin Appl Thromb Hemost 1999, 5:232-5.
17. Giral P, Pithois-Merli I, Filitti V, Levenson J, Plainfosse MC, Mainardi C, Simon AC. Risk factors and early extracoronary atherosclerotic plaques detected by three-site ultrasound imaging in hypercholesterolemic men: Prevention Cardiovasculaire en Medecine du Travail METRA Group. Arch Intern Med 1991, 151:950-6.
18. Joensuu T, Salonen R, Winblad I, Korpela H, Salonen JT. Determinants of femoral and carotid artery atherosclerosis. J Intern Med 1994, 236:79-84.
19. Fuster V, Fayad ZA, Badimon JJ. Acute coronary syndromes: biology. Lancet 1999, 353:S115-9.
20. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernandez-Ortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V, Badimon JJ. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997, 95:594-9.
21. Ananyeva NM, Kouiavskaia DV, Shima M, Saenko EL. Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque. Blood 2002, 99:4475-85.
22. Rosendaal FR, Briët E, Stibbe J, Leuven JAG, Hofman A, Vandenbroucke JP. Haemophilia protects against ischaemic heart disease: a study of risk factors. Br J Haematol 1990, 75:525-30.